|3HEG: P38 In Complex With Sorafenib |
reference: Analysis of imatinib and sorafenib binding to p38alpha compared with c-Abl and b-Raf provides structural insights for understanding the selectivity of inhibitors targeting the DFG-out form of protein kinases., Namboodiri HV, Bukhtiyarova M, Ramcharan J, Karpusas M, Lee Y, Springman EB, Biochemistry. 2010 May 4;49(17):3611-8. PMID: 20337484
uses Jmol, developed by the Jmol Development Team (documentation).